Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
about
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell linesPhysical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments.
P2860
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Healthy CD4+ T lymphocytes are ...... acute lymphoblastic leukemia.
@en
Healthy CD4+ T lymphocytes are ...... acute lymphoblastic leukemia.
@nl
type
label
Healthy CD4+ T lymphocytes are ...... acute lymphoblastic leukemia.
@en
Healthy CD4+ T lymphocytes are ...... acute lymphoblastic leukemia.
@nl
prefLabel
Healthy CD4+ T lymphocytes are ...... acute lymphoblastic leukemia.
@en
Healthy CD4+ T lymphocytes are ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P50
P356
P1433
P1476
Healthy CD4+ T lymphocytes are ...... l acute lymphoblastic leukemia
@en
P2093
Alberto M Martelli
Arianna Gonelli
Carolina Simioni
Giorgia Marisi
Giorgio Zauli
Luca M Neri
Paola Ulivi
Simona Ultimo
P2860
P304
55690-55703
P356
10.18632/ONCOTARGET.10984
P407
P577
2016-08-01T00:00:00Z